DOI QR코드

DOI QR Code

Status Quo of Chronic Liver Diseases, Including Hepatocellular Carcinoma, in Mongolia

  • Published : 2012.06.01

Abstract

Because Mongolia has much higher liver disease burden than any other regions of the world, it is necessary to provide information on real-time situation of chronic liver disease in Mongolia. In this article, we reviewed studies performed in Mongolia from 2000 to 2011 on seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among healthy individuals and patients with chronic liver diseases, and on the practice patterns for the management of liver cirrhosis and hepatocellular carcinoma (HCC). According to previous reports, the seroprevalence of HBV and HCV in general population in Mongolia is very high (11.8% and 15% for HBV and HCV, respectively). Liver cirrhosis is also highly prevalent, and mortality from liver cirrhosis remained high for the past decade (about 30 deaths per 100,000 populations per year). Among patients with cirrhosis, 40% and 39% are positive for HBsAg and anti-HCV, respectively, and 20% are positive for both. The seroprevalence is similar for HCC and more than 90% of HCC paients are positive for either HBV or HCV. The incidence of HCC in Mongolia is currently among the highest in the world. The mortality from HCC is also very high (52.2 deaths per 100,000 persons per year in 2010). Partly due to the lack of established surveillance systems, most cases of HCC are diagnosed at an advanced stage. The mortality from liver cirrhosis and HCC in Mongolia may be reduced by implementation of antiviral therapy program and control of alcohol consumption.

Keywords

References

  1. Ministry of Health. National Health Indicator 2009. Ulaanbaatar: Ministry of Health, 2009.
  2. Nymadawa P. Hepatitis B vaccination: worldwide and in Mongolia. In: 10th National Conference on "Current Topics of Virology"; 2004; Ulaanbaatar, Mongolia.
  3. Baatarkhuu O, Kim DY, Ahn SH, et al. Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int 2008;28:1389-1395. https://doi.org/10.1111/j.1478-3231.2008.01820.x
  4. Cohen J. The scientific challenge of hepatitis C. Science 1999;285:26-30. https://doi.org/10.1126/science.285.5424.26
  5. Stark K, Poggensee G, Hohne M, Bienzle U, Kiwelu I, Schreier E. Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania. J Med Virol 2000;62:524-530. https://doi.org/10.1002/1096-9071(200012)62:4<524::AID-JMV19>3.0.CO;2-N
  6. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-891. https://doi.org/10.1016/S0140-6736(99)06527-7
  7. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005;150:2513-2528. https://doi.org/10.1007/s00705-005-0590-1
  8. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 2005;77:491-499. https://doi.org/10.1002/jmv.20482
  9. Dondog B, Lise M, Dondov O, Baldandorj B, Franceschi S. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Eur J Cancer Prev 2011;20:33- 39. https://doi.org/10.1097/CEJ.0b013e32833f0c8e
  10. Kurbanov F, Tanaka Y, Elkady A, Oyunsuren T, Mizokami M. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia. J Viral Hepat 2007;14:667-674. https://doi.org/10.1111/j.1365-2893.2007.00864.x
  11. Oyunsuren T, Kurbanov F, Tanaka Y, et al. High frequency of hepatocellular carcinoma in Mongolia: association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 2006;78:1688-1695. https://doi.org/10.1002/jmv.20755
  12. Oyunsuren T, Sanduijav R, Davaadorj D, Nansalmaa D. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia. Asian Pac J Cancer Prev 2006;7:460-462.
  13. Jazag A, Puntsagdulam N. Demography and mortality of patients undergone liver resection due to HCC at National Cancer Center in Mongolia. In: APASL 2nd Hepatocellular carcinoma Conference; 2011 Dec 1-3; Jeju, Korea.

Cited by

  1. A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection vol.20, pp.12, 2012, https://doi.org/10.1111/jvh.12121
  2. Impact of Glissonean Pedicle Approach for Centrally Located Hepatocellular Carcinoma in Mongolia vol.100, pp.2, 2012, https://doi.org/10.9738/intsurg-d-14-00006.1
  3. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries vol.9, pp.4, 2012, https://doi.org/10.1007/s12072-015-9630-4
  4. Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia vol.3, pp.1, 2012, https://doi.org/10.1136/bmjgast-2016-000119
  5. Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L vol.4, pp.None, 2017, https://doi.org/10.2147/jhc.s122507
  6. Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis vol.23, pp.2, 2017, https://doi.org/10.3350/cmh.2016.0055
  7. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12 vol.140, pp.2, 2012, https://doi.org/10.1002/ijc.30463
  8. Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea vol.59, pp.9, 2018, https://doi.org/10.3349/ymj.2018.59.9.1072
  9. Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia vol.8, pp.1, 2012, https://doi.org/10.5005/jp-journals-10018-1260
  10. A Review of the Potential Benefits of Increasing Vitamin D Status in Mongolian Adults through Food Fortification and Vitamin D Supplementation vol.11, pp.10, 2012, https://doi.org/10.3390/nu11102452